MetaCap

EyePoint (EYPT) vs Rapid Micro Biosystems (RPID)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Rapid Micro Biosystems (RPID) has outperformed EyePoint (EYPT) over the past year, losing 82.4% versus a loss of 98.3%. Over five years, RPID leads with a -94.4% price change compared with -98.6% for EYPT. Rapid Micro Biosystems is the larger company by market cap ($37.4 million vs $26.6 million), about 1.4 times the size.

Rapid Micro Biosystems converts more of its revenue into profit, with a net margin of -140.3% versus -739.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EYPT-98.29%RPID-82.37%
+45%-30%-105%
Nov 21, 20251 yearNov 20, 2026
EYPT-98.64%RPID-95.40%
+75%-16%-107%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EYPT versus RPID key metrics
MetricEYPTRPID
Share price$0.2342$0.735
Market cap$26.65M$37.37M
1-day change-11.36%-0.04%
YTD return-98.72%-74.66%
1-year return-98.29%-82.37%
5-year return-98.58%-94.41%
EPS (TTM)$-3.97$-1.06
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$31.37M$33.59M
Revenue growth (YoY)-27.50%+19.74%
Net income (latest FY)$-231.96M$-47.12M
Operating margin-775.98%-141.10%
Net margin-739.42%-140.30%
52-week high$19.11$4.94
52-week low$0.2277$0.58
Distance from 52-week high-98.77%-85.12%
Analyst consensusbuystrong_buy
Avg. price target upside+10963.19%+682.31%
Average volume8.37M577.05K
Shares outstanding113.78M46.34M
Employees214171
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RPID has outperformed EYPT by 15.9 percentage points over the past year.
  • Rapid Micro Biosystems is more profitable, keeping -140.3 cents of every revenue dollar as net income versus -739.4 cents for EyePoint.
  • Rapid Micro Biosystems grew revenue faster in its latest fiscal year (+19.74% vs -27.50%).

About EyePoint

EYPT stock →

EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees

About Rapid Micro Biosystems

RPID stock →

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees

EYPT vs RPID FAQ

Which is bigger, EyePoint or Rapid Micro Biosystems?

Rapid Micro Biosystems (RPID) is larger, with a market capitalization of $37.37M compared with $26.65M for EyePoint (EYPT).

Which stock has performed better over the past year, EYPT or RPID?

RPID returned -82.37% over the past 12 months, compared with -98.29% for EYPT (price return, excluding dividends). Past performance does not predict future results.

Are EyePoint and Rapid Micro Biosystems in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons